Dyadic International Inc.

11/10/2025 | Press release | Distributed by Public on 11/10/2025 06:28

Dyadic Applied BioSolutions Expands Genetic Engineering Capabilities Through CRISPR/Cas9 Commercial License with ERS Genomics

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.
Dyadic International Inc. published this content on November 10, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 10, 2025 at 12:29 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]